Author

Špela Pintar 1

1 University Medical Centre Ljubljana, Ljubljana, Slovenia

CLINICAL AND BIOMARKER REMISSION IS MAINTAINED AFTER SWITCH FROM MONTHLY DOSED VEDOLIZUMAB TO THE NOVEL SUBCUTANEOUS FORMULATION IN INFLAMMATORY BOWEL DISEASE

Špela Pintar, Jurij Hanzel, Natasa Smrekar, Matic Koželj, David Drobne, Tina Kurent, Borut Stabuc, Gregor Novak

CLOSTRIDIUM DIFFICILE ISOLATION AND CHARACTERISATION - RESULTS OF A PILOT STUDY

Špela Pintar, Maja Rupnik, Pavel Skok

Item 1 - 2 / 2
1